Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort ascending

Gerd Rippin, Nicolás Ballarini, Héctor Sanz, Joan Largent, Chantal Quinten & Francesco Pignatti

 July 2022 A Review of Causal Inference for External Comparator Arm Studies Springer Nature Switzerland AG

Daniele Modonutti MD,Sami E. Majdalany MD,Nicholas Corsi BS,Pin Li PhD,Akshay Sood MD,Deepansh Dalela MD,Marcus L. Jamil MD,Clara Hwang MD,Mani Menon MD,Craig G. Rogers MD,Quoc-Dien Trinh MD,Giacomo Novara MD,Firas Abdollah MD

 July 2022 A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis The Prostate

Michael J. Kane

 June 2021 Towards a Grammar for Processing Clinical Trial Data R Journal Volume

Jiang Y, Cai D, Shi S

 April 2022 Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies Dovepress

Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho

 April 2022 Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials Sage Journals

Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai 

 March 2022 Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? Therapeutic Innovation & Regulatory Science

T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry

 March 2022 Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel Clinical Oncology

Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth,  Pekka Tiikkainen, Harri Lähdesmäki

 March 2022 Learning Conditional Variational Autoencoders with Missing Covariates arXiv

Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov

 January 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT

Yu, Peter MD, ET AL

 February 2022 Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times

Liling Huang , Shiyu Jiang  & Yuankai Shi 

 February 2022 Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data futuremedicine

Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger 

 February 2022 Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications

Giorgos Bakoyannis, Dipankar Bandyopadhyay

 November 2021 Nonparametric tests for multistate processes with clustered data AISM

Fadi S.Dahdaleh, Scott K.Sherman, Hunter D.D.Witmer, Ankit Dhiman, Rahul Rajeev, Elizabeth C.Poli, Fabian M.Johnston, Kiran K.Turagaa

 January 2022 Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery

Pages